Denali Therapeutics Inc. (DNLI) PT Raised to $87 at Goldman Sachs
Tweet
Share
E-mailGet Alerts DNLI Hot Sheet
Price: $14.83 -4.69%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $87.00 (from $77.00) while maintaining a Buy rating.
You May Also Be Interested In
- Teradyne (TER) PT Raised to $125 at TD Cowen
- TechnipFMC (FTI) PT Raised to $30 at BTIG
- Oxford Instruments Plc. (OXIG:LN) (OXINF) PT Raised to GBP25 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
